| Literature DB >> 30076218 |
Yasutaka Mitamura1,2, Satoshi Nunomura1, Yasuhiro Nanri1, Kazuhiko Arima1, Tomohito Yoshihara1, Kosaku Komiya1,3, Shogo Fukuda1, Hiroaki Takatori4, Hiroshi Nakajima4, Masutaka Furue2, Kenji Izuhara5.
Abstract
Interleukin (IL)-13 is a signature cytokine of type 2 inflammation important for the pathogenesis of various diseases, including allergic diseases. Signal transducer and activator of transcription (STAT) 6 is a critical transcriptional factor for the IL-13 signals; however, it remains unknown how expression of the IL-13-induced genes is differentiated by the transcriptional machineries. In this study, we identified IL-13-induced transcriptional factors in lung fibroblasts using DNA microarrays in which SOX11 was included. Knockdown of SOX11 down-regulated expression of periostin and CCL26, both of which are known to be downstream molecules of IL-13, whereas enforced expression of SOX11 together with IL-13 stimulation enhanced expression of periostin. Moreover, we found that in DNA microarrays combining IL-13 induction and SOX11 knockdown there exist both SOX11-dependent and -independent molecules in IL-13-inducible molecules. In the former, many inflammation-related and fibrosis-related molecules, including periostin and CCL26, are involved. These results suggest that SOX11 acts as a trans-acting transcriptional factor downstream of STAT6 and that in lung fibroblasts the IL-13 signals are hierarchically controlled by STAT6 and SOX11.Entities:
Keywords: STAT transcription factor; allergy; cell signaling; cytokine; fibroblast; fibrosis; interleukin; transcription
Mesh:
Substances:
Year: 2018 PMID: 30076218 PMCID: PMC6153291 DOI: 10.1074/jbc.RA117.001364
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157